Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
234.55
-0.58 (-0.25%)
At close: Aug 28, 2026, 4:00 PM EDT
232.64
-1.91 (-0.81%)
After-hours: Aug 28, 2026, 7:55 PM EDT
Cardinal Health Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Cardinal Health stock has a consensus rating of "Buy" and an average price target of $270.94. The average 1-year stock price forecast is 15.51% higher than the current stock price, while the lowest is $235 (+0.19%) and the highest is $292 (+24.49%).
Price Target: $270.94 (+15.51%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cardinal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 12 | 12 | 12 | 12 |
| Buy | 2 | 3 | 2 | 2 | 2 | 3 |
| Hold | 4 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 17 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Reiterates $275 | Buy | Reiterates | $275 | +17.25% | Aug 19, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $276 | Buy | Initiates | $276 | +17.67% | Aug 19, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $260 | Hold | Maintains | $260 | +10.85% | Aug 17, 2026 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $223 → $261 | Hold | Maintains | $223 → $261 | +11.28% | Aug 13, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $240 → $250 | Buy | Maintains | $240 → $250 | +6.59% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
265.72B
from 254.25B
Increased by 4.51%
Revenue Next Year
281.80B
from 265.72B
Increased by 6.05%
EPS This Year
12.57
from 10.95
Increased by 14.76%
EPS Next Year
14.08
from 12.57
Increased by 12.02%
EPS and Forward PE are based on non-GAAP adjusted numbers.